- The benefits of the first option include: (i) greater clarity in the design and increased ease in the review and monitoring of
the clinical trial because only pregnant women are included in the trial; (ii) the use of safety end points that are specific for
pregnant women and that build effectively on the knowledge gained from previous trials in nonpregnant adults; (iii) the
option of phased enrollment so that pregnant women in the later stages of pregnancy can be enrolled in research before
women in the first trimester of their pregnancy are enrolled; (iv) increased probability that there will be planning for
counselling regarding potential risks for the pregnancy; (v) increased probability that there will be planning for long-term
follow-up of newborns; (vi) greater ease in recruiting qualified investigators and trial participants; (vii) the possibility of
reduced liability issues and (viii) timely analysis and reporting of data from pregnant participants.